Noninterventional Examination of Subcutaneous (sc) Tumor Necrosis Factor (TNF) Inhibitors

Certolizumab Pegol for the Treatment of Patients With Active Rheumatoid Arthritis

NCT00717236 ·Status: COMPLETED ·Phase: PHASE3

Scintigraphic Detection of the Biodistribution of Tumor Necrosis Factor With a Radiolabeled Anti-TNFα in Patients With Active Rheumatoid Arthritis and Active Axial and Peripheral Spondyloarthritis

NCT01590966 ·Status: COMPLETED ·Phase: PHASE3

Open Label Study to Assess the Predictability of Early Response to Certolizumab Pegol in Patients With Rheumatoid Arthritis

NCT01443364 ·Status: COMPLETED ·Phase: PHASE4

A Study of Subcutaneously Administered Tocilizumab in Participants With Systemic Juvenile Idiopathic Arthritis

NCT01904292 ·Status: COMPLETED ·Phase: PHASE1

A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adults With Early Active Rheumatoid Arthritis

NCT01519791 ·Status: COMPLETED ·Phase: PHASE3

A Study Evaluating the Efficacy and Safety of Guselkumab Administered Subcutaneously in Participants With Active Psoriatic Arthritis Including Those Previously Treated With Biologic Anti -Tumor Necrosis Factor (TNF) Alpha Agent(s)

NCT03162796 ·Status: COMPLETED ·Phase: PHASE3

Rheumatoid Arthritis (RA) Moderate to Low Disease Activity Study

NCT00674362 ·Status: COMPLETED ·Phase: PHASE3

Can TNF-Alpha Incomplete Secondary Responders Attain a Safe and Efficacious Response Switching to Cimzia

NCT01147341 ·Status: COMPLETED ·Phase: PHASE4

A Trial of NNC0109-0012, an Anti-IL-20 Biologic, in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to Anti-TNFa Biologics

NCT01636817 ·Status: TERMINATED ·Phase: PHASE2

A Study to Evaluate Tocilizumab Treatment in a Real-Life Setting

NCT01664104 ·Status: COMPLETED

A Retrospective Observational Study on Compliance in Patients With Rheumatoid Arthritis on Treatment With RoActemra/Actemra (Tocilizumab) in Clinical Practice (REMISSION II)

NCT01649817 ·Status: COMPLETED

A Trial of NNC0109-0012, an Anti-IL-20 Biologic, in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to Methotrexate

NCT01636843 ·Status: TERMINATED ·Phase: PHASE2

An Global Comparative Observational Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis

NCT01543503 ·Status: COMPLETED

A Study of Tocilizumab in Participants With Active Rheumatoid Arthritis (RA) and an Inadequate Response to Non-Biological Disease-modifying Anti-rheumatic Drugs (DMARDs)

NCT01617005 ·Status: COMPLETED

Study of the Tolerability of Different SAR153191 Drug Products, That Differ With Respect to Manufacturing Processes and Formulation, at Different Concentrations and Doses in Healthy Male Subjects

NCT06159452 ·Status: COMPLETED ·Phase: PHASE1

Dosing Flexibility Study in Patients With Rheumatoid Arthritis

NCT00580840 ·Status: COMPLETED ·Phase: PHASE4

A Study of the Safety and Effectiveness of Liquid Certolizumab Pegol in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis

NCT00160641 ·Status: COMPLETED ·Phase: PHASE3

A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adults With Early Active Rheumatoid Arthritis

NCT01521923 ·Status: COMPLETED ·Phase: PHASE3

A Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of Subcutaneous AZD6912 in Healthy Participants

NCT06115967 ·Status: COMPLETED ·Phase: PHASE1

Evaluating the Safety of Extended Treatment With Pegsunercept (PEG sTNF-RI)in Subjects With Rheumatoid Arthritis (RA)

NCT00111423 ·Status: COMPLETED ·Phase: PHASE2

Health-related Quality of Life and Patient-reported Outcomes in Rheumatoid Arthritis Patients Treated With Certolizumab Pegol

NCT01526434 ·Status: COMPLETED

Certolizumab Pegol in Subjects With Adult Onset Active and Progressive Psoriatic Arthritis

NCT01087788 ·Status: COMPLETED ·Phase: PHASE3

Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Effects of Multiple Rising Subcutaneous Doses of BI 655064 in Healthy Volunteers and in Rheumatoid Arthritis Patients With Prior Inadequate Response to Methotrexate Therapy

NCT01751776 ·Status: COMPLETED ·Phase: PHASE1

An Observational Study of MabThera/Rituxan (Rituximab) and Alternative TNF-Inhibitors in Patients With Rheumatoid Arthritis and an Inadequate Response to a Single Previous TNF-Inhibitor

NCT01557348 ·Status: COMPLETED

Certolizumab Pegol in Subjects With Active Axial Spondyloarthritis

NCT01087762 ·Status: COMPLETED ·Phase: PHASE3